The effect of HS-111, a novel thiazolamine derivative, on apoptosis and angiogenesis of hepatocellular carcinoma cells
Archives of Pharmacal Research, 05/24/2012Choi MJ et al.
These results showed that HS–111 not only inhibited cell growth and angiogenesis, but also induced apoptosis of human HCC cells. Authors suggest that HS–111 may be a potential candidate for chemotherapy against HCC.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.